Picture EBD Group BioPharm America 2020 Digital Event BEU2020 650x81
Document › Details

Hyloris Pharmaceuticals S.A.. (6/3/20). "Press Release: Hyloris Pharmaceuticals Announces Intention to Launch an Initial Public Offering on Euronext Brussels [Not for US, AU, CA, CH, IL, JP or ZA]". Liège.

Organisations Organisation Hyloris Pharmaceuticals S.A.
  Organisation 2 Euronext Brussels
  Group Euronext (Group)
Products Product pharmaceutical
  Product 2 investment banking
Index term Index term Hyloris Pharmaceuticals–SEVERAL: investment, 202006– IPO with 5m+750k shares at price range of €10.0 to €11.5 at Euronext Brussels
Persons Person Van Rompay, Stijn (Hyloris Pharmaceuticals 202004 CEO + Co-Founder)
  Person 2 Jeanmart, Patrick (Hyloris Pharmaceuticals 202004– CFO acting through PaJe SRL before Degroof Petercam + Celyad + IBA)

Record changed: 2020-06-17


Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

More documents for Hyloris Pharmaceuticals S.A.

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture Kentro Design Corporate and Web Design Berlin 650x65px

» top